Endolytix Technology
BEVERLY, MA · Biotechnology, Healthcare · 9 employees
Endolytix is developing a novel therapeutics to address the most resistant of antibiotic infections that are difficult to treat, and patient tolerance for current therapies are low.
Funding history
- Funding Round — $5.0M — Aug 2024
- Series seed — $4.3M — Sep 2023
- Series seed — $4.3M — Jul 2023
- Funding Round — $12.0M — Mar 2021
Recent signals
- Aug 08, 2024: Raised $5.0M
- Sep 13, 2023: Raised $4.3M in Series seed
- Jul 27, 2023: Raised $4.3M in Series seed
- Mar 26, 2021: Raised $12.0M
See plans & pricing → Track Endolytix Technology’s funding, hiring, and signals — with verified contacts — on Fundz.